BiochemistrybioRxivPreprint
The Cdc42 effector and non-receptor tyrosine kinase, ACK defines a distinct STAT5 transcription signature in a chronic myeloid leukaemia cell model
J. Corry, D. Jachimowicz, B. Keith…·D. Owen
The paper shows ACK enhances STAT5 transcriptional activity in K562 cells and identifies an ACK-driven STAT5 signature, suggesting a therapeutic target in CML.
DOI 10.1101/2022.06.10.494364